Construction is underway on phase two of the 7.1-acre Roebling Center redevelopment project, a collection of five former industrial buildings in Trenton, New Jersey that are being transformed into a residential, commercial, and entertainment destination.
Hx2 Development and JLL were selected by Trenton officials to complete the second phase of redevelopment, which includes a new 100,000-square-foot life sciences and pharmaceutical research building. The existing property, known as Building 114, will be equipped with modern ventilation systems, large factory-style windows, skylights, and ceiling spans as high as 24 feet.
“The unique needs of the life science sector make Building 114 an ideal location,” said David Henderson, principal of Hx2 Development. “We will deliver the property ready for a custom buildout at a time when leading companies continue to actively pursue Class A R&D and lab spaces in one of the nation’s most competitive life sciences real estate markets.”
The Roebling Center complex is bound by New Jersey Route 1 and South Broad Street to the west and south, Clark and Mott Streets to the north, and Dye Street to the east. The site is also immediately adjacent to the Hamilton Avenue light rail station and not far from the Trenton Transit Center, which offers connections to New York City, Newark Airport, Philadelphia, and AMTRAK rail lines.
JLL was selected as exclusive marketing and sales agent for Roebling Center properties.
Subscribe to YIMBY’s daily e-mail
Follow YIMBYgram for real-time photo updates
Like YIMBY on Facebook
Follow YIMBY’s Twitter for the latest in YIMBYnews
I grew up near Trenton and experienced its decline and fall in the 1960s. Were it not for the many state office buildings, it would likely be similar to Detroit today. I wish Trenton well, but the city has to recover somewhat more before it is attractive to companies.